Oncology Central

EN2: a novel prostate cancer biomarker

0

Extensive efforts to identify a clinically useful biomarker for the diagnosis of prostate cancer have resulted in important insights into the biology of the disease, but no new test has been approved by regulatory authorities. The unmet need has also shifted to identifying biomarkers that not only diagnose prostate cancer but also indicate whether the patient has ‘significant’ disease.

To view restricted content, please:
Share:

Leave A Comment